Does antibody-dependent epitope masking permit progressive tumour growth in the face of cell-mediated cytotoxicity?
Open Access
- 1 October 1991
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 12 (10) , 352-355
- https://doi.org/10.1016/0167-5699(91)90065-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Progressive Tumor Growth and Immune ResponsesaAnnals of the New York Academy of Sciences, 1988
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Down-Regulation of the Antitumor Immune ResponseAdvances in Cancer Research, 1985
- Biological and Clinical Implications of Lymphocyte Hybridomas: Tumor Therapy with Monoclonal AntibodiesAnnual Review of Medicine, 1983
- T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.The Journal of Experimental Medicine, 1981
- Characterization and Specificity of Murine Anti-Tumor Cytotoxic Effector Cells within an Ascitic TumorThe Journal of Immunology, 1977
- Tumor-Bound Immunoglobulins:in SituExpressions Of Humoral ImmunityPublished by Elsevier ,1977
- A simplified 51Cr-release assay for killer cellsJournal of Immunological Methods, 1974
- A Microtest Radioimmunoassay for Noncytotoxic Tumor-Specific Antibody to Cell-Surface Antigens2JNCI Journal of the National Cancer Institute, 1973
- Immunological Enhancement: A Study of Blocking AntibodiesPublished by Elsevier ,1972